Lifecare’s Chief Scientific Officer, Prof. Dr. Dr. med Andreas Pfützner, holdshare option rights both personally and through his company Islay Ventures GmbH.The share option agreement with Islay Ventures GmbH includes 521.321 shareoptions in total and the exercise right is based on a detailed milestone plan.In addition, Islay Ventures GmbH hold 578.125 shares in Lifecare AS. Prof. Dr. Dr. med Pfützner has notified Lifecare AS that Islay Venture GmbH willexercise share options to the extend the milestones is achieved, and on thisbase announces the exercise of 325.826 share options. The exercised shareoptions have each a strike price of NOK 0,40-. The new shares will be issued based on an authorization to increase the sharecapital granted to the Board of Directors of Lifecare AS. The share issue isexpected to be completed by the end of August 2020. The remaining 195.495 share options under this agreement must be exercised byOctober 1st 2021. In addition, Prof. Dr. Dr. med Pfützner hold 3.524.927 shareoptions at a strike price of NOK 1,70,- to be exercised by February 20th, 2022. This information is subject to the disclosure requirements pursuant to Sections4-2 and 5-12 of the Norwegian Securities Trading Act.